Article
Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
Breast cancer (Tokyo, Japan) - 1 Sept 2022
Minoura Yuko, Takahashi Masato, Maeda Hideki, Kuwahara Sayuri, Tachikawa Hanae, Yamamoto Mitsugu, Tomioka Nobumoto, Watanabe Kenichi, Sakurai Akihiro
Abstract excerpt
BACKGROUND: When considering BRCA1/2 genetic testing for diagnosis of hereditary breast and ovarian cancer (HBOC), family history (FH) of breast and ovarian cancer is commonly considered. However, FH of other HBOC-related cancers, such as prostate, pancreatic, and skin cancer (malignant melanoma), is often overlooked. METHODS: Among 945 patients who received genetic testing of BRCA1/2 at our hospital between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
